AN APPRECIATION OF THE ARMED FORCES: WEEKLONG ACTIONS ACROSS MULTIPLE THEATRES. (PHOTO). #PRESS RELEASE

Image
 An appreciation of the armed forces: weeklong actions across multiple theatres By Bayo Onanuga Some Nigerians and armchair analysts are often quick to criticise the Federal Government for perceived shortcomings in security, highlighting isolated incidents such as kidnappings, improvised explosive devices, suicide bombings, and attacks in parts of the country. Such perceptions, however, tend to downplay and discount the heroic exploits of members of the Nigerian armed forces, saddled with the responsibility of countering the evil machinations of God-forsaken non-state actors, who operate like guerrillas.  My position is reinforced by the security reports I receive daily from Zagazola Makama, a journalist who has emerged as a counter-insurgency expert in Nigeria. This past week alone, Zagazola inundated me with reports from multiple theatres, indicating that our troops are making significant gains in the asymmetrical war against insurgents, terrorists, ISWAP, Boko Haram, IPOB, ...

EU REGULATOR APPROVES INJECTABLE HIV DRUG AIMED AT PREVENTING TRANSMISSION. (PHOTO).


 EU regulator approves injectable HIV drug aimed at preventing transmission

The European Medicines Agency has recommended the approval of a twice-yearly injectable drug designed to prevent HIV infection, a development that researchers believe could significantly curb transmission of the virus. The drug, lenacapavir, which will be marketed in Europe under the name Yeytuo by Gilead Sciences, was described by the agency as “highly effective” and of “major public health interest.” If the European Commission accepts this guidance, the authorization will apply across all 27 EU countries, as well as Iceland, Norway, and Liechtenstein. Clinical studies conducted last year showed that lenacapavir, already used to treat individuals living with HIV, was almost 100% effective in preventing transmission in both men and women.


Public health officials, including Winnie Byanyima, the executive director of the United Nations AIDS agency, have described lenacapavir as a potential game changer in the fight against HIV, provided that it is made widely accessible. The drug, which was authorized for prevention by the U.S. Food and Drug Administration in June, has also been recommended by the World Health Organization as an additional option for people at risk. Unlike daily preventive pills or cabotegravir injections that must be administered every two months, lenacapavir provides protection for six months with a single injection, a feature that could appeal to those who prefer fewer clinic visits and less stigma. Despite its promise, critics have expressed concerns that Gilead’s plan to allow generic production in 120 low-income countries does not cover much of Latin America, where HIV rates, though lower, are rising. UNAIDS estimates that more than 40 million people worldwide live with HIV, with about 630,000 deaths from AIDS-related illnesses reported last year, and has urged global leaders, including President Donald Trump, to work toward making this long-lasting prevention option accessible to those who need it most.


Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

AMBODE,SOYINKA & OTHERS AT THE OFFICIAL LAUNCH OF LAGOS AT 50 YEARS ANNIVERSARY AGAINST 2017.{PHOTOS}.